Skip to search formSkip to main contentSkip to account menu

9-O-methanoprostaglandin I

Known as: 9-O-methano-PGI1, isocarbacyclin 
National Institutes of Health

Related topics

Related topics

6 relations

Narrower (2)

9-O-methano-6 beta-PGI1TEI 7165

Broader (3)

EpoprostenolFibrinolytic AgentsPlatelet Aggregation Inhibitors
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Investigations in the synthesis of isocarbacyclin analogs involving transition metal catalysis with explorations into palladium catalyzed decarboxylation.
Isocarbacyclin, a synthetic form of prostacyclin, has been recognized as a potential neuroprotective drug which could be used for… 
2005
2005
Studies on selectivity in the Pauson-Khand reaction and synthesis of an intermediate of isocarbacyclin
1994
1994
Unnatural prostaglandins of biochemical and physiological significance
Abstract 
1993
1993
Isocarbacyclin with modified alpha-chain and process for producing the same
The present invention is the fact that the α-chain α- phenylene group, a cycloalkylene group or modified thio Fendi group… 
1989
1989
Isocarbacyclin derivatives containing antidiabetic agents.
1987
1987
Synthesis and anti-platelet aggregating activity of 3-hetero analogues of (+)-9(O)-methano-delta 6(9 alpha)-prostaglandin I1.
Optically active 3-hetero analogues of isocarbacyclin (34a, 38, 39, 40 and 42) as well as ω-chain analogues have been synthesized… 
1987
1987
Conformational analysis of a diene analog of isocarbacyclin and prostacyclin.
A diene analog (2) of isocarbacyclin has been found to be a potent inhibitor of platelet aggregation. A molecular mechanics… 
1985
1985
Highly efficient synthesis of carbacyclins and isocarbacyclin.
1984
1984
An improved route to (+)-9(0)-methano-.DELTA.6(9.ALPHA.)-prostaglandin-I1 (isocarbacyclin).